Updated daily
Drug recalls
Every FDA drug recall since 2004 - 18,109 enforcement reports, newest first, with what was recalled, why, the lots and the company. Class I is the most serious.
Class IIIOngoingJan 8, 2025Polyvinyl Alcohol Ophthalmic Solution 1.4%LABELING: LABEL MIX-UPAvKARE · D-0176-2025Class IIIOngoingJan 8, 2025Carboxymethylcellulose Sodium Ophthalmic Solution 0.5% Moisturizing Lubricant Eye DropsLABELING: LABEL MIX-UPAvKARE · D-0175-2025Class IITerminatedJan 8, 2025phenylephrine in 0.9% Sodium Chloride InjLack of Assurance of Sterility: The tamper-evident seal on several of the syringes are not attached upon receipt of shipment.Hikma Injectables USA Inc · D-0174-2025Class IITerminatedJan 8, 2025ketamine inj 50 mg per 1 mLLack of Assurance of Sterility: The tamper-evident seal on several of the syringes are not attached upon receipt of shipment.Hikma Injectables USA Inc · D-0173-2025Class IIOngoingJan 8, 2025Dapsone Gel 7.5%CrystallizationViona Pharmaceuticals Inc · D-0172-2025Class IIOngoingJan 8, 2025Dapsone Gel 7.5%CrystallizationViona Pharmaceuticals Inc · D-0171-2025Class IOngoingJan 8, 2025FORCE FOREVER 400mg TabletsMarketed without an approved NDA/ANDA. FDA analysis found the product to be tainted with Diclofenac and Dexamethasone.GNMart LLC · D-0170-2025Class IIITerminatedJan 8, 2025Atropine Sulfate Ophthalmic SolutionFailed Impurities/Degradation SpecificationsSomerset Therapeutics LLC · D-0169-2025Class IIOngoingJan 8, 2025Nitrofurantoin CapsulesFailed Dissolution SpecificationsAvKARE · D-0168-2025Class IITerminatedJan 8, 2025Levothyroxine Sodium TabletsFailed Impurities/Degradation Specifications: Out of specifications result observed in the drug substance for impurity test during 3-month long term stability study.Lupin Pharmaceuticals Inc. · D-0167-2025Class IIOngoingJan 1, 2025UMARY ACID HYALURONICcGMP Deviations: the firm initiated a recall after notification from the distributor that product may be tainted with undeclared diclofenac and omeprazole, however there...Mxbbb · D-0166-2025Class IIOngoingJan 1, 2025Duloxetine Delayed-Release CapsulesCGMP Deviations; presence of N-nitroso-duloxetine impurity above recommended interim limit.RemedyRepack Inc. · D-0165-2025Class IITerminatedJan 1, 2025Kit for the Preparation of Technetium Tc 99m Sestamibi InjectionLack of Assurance of Sterility; Improper crimps on vials impacting the integrity of the productCurium US, LLC · D-0164-2025Class IITerminatedJan 1, 2025DULoxetine DR USPCGMP Deviations: the presence of a Nitrosamine Drug Substance Related Impurity (NDSRI), N-Nitroso-Duloxetine above the interim acceptable intake limitPD-Rx Pharmaceuticals, Inc. · D-0163-2025Class IIOngoingJan 1, 2025Duloxetine Delayed-Release CapsulesCGMP Deviations: presence of N-nitroso-duloxetine impurity above FDA recommended interim limit.Breckenridge Pharmaceutical, Inc · D-0162-2025Class IIOngoingJan 1, 2025Duloxetine Delayed-Release CapsulesCGMP Deviations: presence of N-nitroso-duloxetine impurity above FDA recommended interim limit.Breckenridge Pharmaceutical, Inc · D-0161-2025Class IICompletedJan 1, 2025chlorproMAZINE Hydrochloride TabletsCGMP Deviations: N-Nitroso-Desmethyl Chlorpromazine impurity (NNDCI) were found to be failing per current FDA recommended limit.Glenmark Pharmaceuticals Inc., USA · D-0160-2025Class IICompletedJan 1, 2025chlorproMAZINE Hydrochloride TabletsCGMP Deviations: N-Nitroso-Desmethyl Chlorpromazine impurity (NNDCI) were found to be failing per current FDA recommended limit.Glenmark Pharmaceuticals Inc., USA · D-0159-2025Class IIOngoingJan 1, 2025Duloxetine Delayed-Release CapsulesCGMP Deviations: Presence of N-nitroso-duloxetine impurity above the recommended interim limit.Amerisource Health Services LLC · D-0158-2025Class IIOngoingJan 1, 2025Duloxetine Delayed-Release Capsules USPCGMP Deviations: Presence of N-nitroso-duloxetine impurity above the recommended interim limit.Amerisource Health Services LLC · D-0157-2025Class IIOngoingJan 1, 2025Duloxetine Delayed-Release CapsulesCGMP Deviations: Presence of N-nitroso-duloxetine impurity above the recommended interim limit.Amerisource Health Services LLC · D-0156-2025Class IIOngoingJan 1, 2025Duloxetine Delayed-Release Capsules USPCGMP Deviations: Presence of N-nitroso-duloxetine impurity above the recommended interim limit.Amerisource Health Services LLC · D-0155-2025Class IIOngoingDec 25, 2024Olanzapine TabletsFailed Impurities/Degradation SpecificationsMacleods Pharmaceuticals Ltd · D-0154-2025Class IITerminatedDec 25, 2024PROFESSIONAL Regener-EyesLack of Sterility AssuranceRegenerative Processing Plant, LLC · D-0153-2025Class IITerminatedDec 25, 2024LITE Regener-EyesLack of Sterility AssuranceRegenerative Processing Plant, LLC · D-0152-2025Class IIOngoingDec 25, 2024VCF, Vaginal Contraceptive GelCGMP deviations: out of specifications for assayApothecus Pharmaceutical Corp. · D-0151-2025Class IIOngoingDec 25, 2024Dihydroergotamine Mesylate InjectionDiscolorationProvepharm Inc. · D-0150-2025Class IIOngoingDec 25, 2024Nebivolol TabletsCGMP Deviations: Presence of Nitrosamine Drug Substance Related Impurity (NDSRI), N-Nitroso Nebivolol above acceptable intake (AI) limit.Aurobindo Pharma USA Inc · D-0149-2025Class IITerminatedDec 25, 2024Henry ScheinCGMP deviations: the bulk product was rejected by the Quality Unit after routine inspection of the mixing vessel showed scratches on the sides and bottom of the mixing...Keystone Industries · D-0148-2025Class IITerminatedDec 25, 2024Ipana, 20% Benzocaine Topical GelCGMP deviations: the bulk product was rejected by the Quality Unit after routine inspection of the mixing vessel showed scratches on the sides and bottom of the mixing...Keystone Industries · D-0147-2025Class IITerminatedDec 25, 2024Quala Dental ProductsCGMP deviations: the bulk product was rejected by the Quality Unit after routine inspection of the mixing vessel showed scratches on the sides and bottom of the mixing...Keystone Industries · D-0146-2025Class IITerminatedDec 25, 2024safco, SensiCaine UltraCGMP deviations: the bulk product was rejected by the Quality Unit after routine inspection of the mixing vessel showed scratches on the sides and bottom of the mixing...Keystone Industries · D-0145-2025Class IITerminatedDec 25, 2024Pearson QualityCGMP deviations: the bulk product was rejected by the Quality Unit after routine inspection of the mixing vessel showed scratches on the sides and bottom of the mixing...Keystone Industries · D-0144-2025Class IITerminatedDec 25, 2024BurkhartCGMP deviations: the bulk product was rejected by the Quality Unit after routine inspection of the mixing vessel showed scratches on the sides and bottom of the mixing...Keystone Industries · D-0143-2025Class IITerminatedDec 25, 2024Health-TecCGMP deviations: the bulk product was rejected by the Quality Unit after routine inspection of the mixing vessel showed scratches on the sides and bottom of the mixing...Keystone Industries · D-0142-2025Class IITerminatedDec 25, 2024Patterson DentalCGMP deviations: the bulk product was rejected by the Quality Unit after routine inspection of the mixing vessel showed scratches on the sides and bottom of the mixing...Keystone Industries · D-0141-2025Class IITerminatedDec 25, 2024Dental CityCGMP deviations: the bulk product was rejected by the Quality Unit after routine inspection of the mixing vessel showed scratches on the sides and bottom of the mixing...Keystone Industries · D-0140-2025Class IITerminatedDec 25, 2024Primo, Topical Anesthetic gelCGMP deviations: the bulk product was rejected by the Quality Unit after routine inspection of the mixing vessel showed scratches on the sides and bottom of the mixing...Keystone Industries · D-0139-2025Class IITerminatedDec 25, 2024M&S Dental Supply Co LLCCGMP deviations: the bulk product was rejected by the Quality Unit after routine inspection of the mixing vessel showed scratches on the sides and bottom of the mixing...Keystone Industries · D-0138-2025Class IITerminatedDec 25, 2024Gelato, Benzocaine 20% Topical Gel Anesthetic GelCGMP deviations: the bulk product was rejected by the Quality Unit after routine inspection of the mixing vessel showed scratches on the sides and bottom of the mixing...Keystone Industries · D-0137-2025